Envestnet Asset Management Inc Chemomab Therapeutics Ltd. Transaction History

Envestnet Asset Management Inc

  • $263 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
BUY
$1.9 - $3.2 $2,175 - $3,664
1,145 Added 9.77%
12,861 $41,000
Q3 2022

Nov 10, 2022
SELL
$2.47 - $4.0 $1,178 - $1,908
-477 Reduced 3.91%
11,716 $29,000
Q2 2022

Aug 03, 2022
BUY
$2.58 - $4.88 $3,575 - $6,763
1,386 Added 12.83%
12,193 $45,000
Q1 2022

May 04, 2022
BUY
$3.53 - $7.2 $38,148 - $77,810
10,807 New
10,807 $52,000

Others Institutions Holding CMMB

# of Institutions
16
Shares Held
2.66M
Call Options Held
0
Put Options Held
0
View Full List

About Chemomab Therapeutics Ltd.

CMMB Quotes by TradingView
  • Ticker CMMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,431,700
  • Market Cap $11.1M
  • Description
  • Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...
More about CMMB
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email